AZD0424
Catalog No. A19488
AZD0424 is an orally active, and dual selective Src/Abl kinase inhibitor with potential antineoplastic activity. AZD0424 induces apoptosis and cell cycle arrest in lymphoma cells.
| Catalog Num | A19488 |
|---|---|
| M. Wt | 528.99 |
| Formula | C25H29ClN6O5 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 692054-06-1 |
| Synonyms | AZD 0424, AZD-0424 |
| SMILES | CC(N1CCN(CCOC2=CC3=NC=NC(NC4=C(OCO5)C5=NC=C4Cl)=C3C(OC(C)C)=C2)CC1)=O |
AZD0424 is an orally active, and dual selective Src/Abl kinase inhibitor with potential antineoplastic activity. AZD0424 induces apoptosis and cell cycle arrest in lymphoma cells.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 18.9 mL | 94.52 mL | 189.04 mL |
| 0.5 mM | 3.78 mL | 18.9 mL | 37.81 mL |
| 1 mM | 1.89 mL | 9.45 mL | 18.9 mL |
| 5 mM | 0.38 mL | 1.89 mL | 3.78 mL |
*The above data is based on the productmolecular weight 528.99. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.